{
    "id": 17987,
    "cites": 22,
    "cited_by": 6,
    "reference": [
        "Clemens, Jeffrey and Joshua Gottlieb. \u00c3\u0082\u00c2\u00a02012. \u00c3\u0082\u00c2\u00a0",
        "Federal Drug Administration. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Transcript of Drug Shortage Workshop.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d http://www.fda.gov/downloads/Drugs/NewsEvents/UCM275801.pdf. September 26, 2011.",
        "Dana, James D., Jr. 2001. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Competition in Price and Availability When Availability is Unobservable. \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The RAND Journal of Economics, 32(3): pp. 497\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c513.",
        "Deneckere, Raymond, and James Peck. 1995. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Competition Over Price and Service Rate When Demand is Stochastic: A Strategic Analysis.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The RAND Journal of Economics, 26(1): pp. 148\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 162.",
        "Emmanuel, Ezekiel J. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Shortchanging Cancer Patients.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New York Times Op-Ed. August 6, 2011.",
        "Cutler, David M. 1998. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Cost Shifting or Cost Cutting?: The Incidence of Reductions in Medicare Payments.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Tax Policy and the Economy, 12: pp. 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c27.",
        "Crawford, Gregory S., and Ali Yurukoglu. 2012. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Welfare Effects of Bundling in Multichannel Television Markets.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Forthcoming, The American Economic Review.",
        "Carlton, Dennis W. 1978. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Market Behavior with Demand Uncertainty and Price Inflexibility.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The American Economic Review, 68(4): pp. 571\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c587.",
        "Berndt, Ernst R. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Report of Independent Expert Prof. Ernest Berndt to Judge Patti B. Saris.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d United States District Court of Massachusetts.",
        "Berndt, Ernst R. 2002. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Journal of Economic Perspectives, 16(4): pp. 45\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c66.",
        "American Society of Hematology. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Prescription Drug Shortages: Examining a Public Health Concern and Potential Solutions.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Testimony to Committee On Health, Education, Labor and Pensions, U.S. Senate. December 15, 2011.",
        "American Society of Clinical Oncology. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Testimony of W. Charles Penley, MD.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Subcommittee on Health of the Committee on Energy and Commerce: Hearing Examining the Increase in Drug Shortages. September 23, 2011.",
        "American Society of Anesthesiologists. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The Anesthesia Perspective: The Impact of Drug Shortages on Patients and Practitioners.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Presentation to FDA. September 27, 2010.",
        "Finkelstein, Amy. 2004. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The Quarterly Journal of Economics, 119(2): pp. 527\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c564.",
        "Fox, Erin R., Annette Birt, Ken B. James, Heather Kokko, Sandra Salverson, and Donna L. Soflin. 2009. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093ASHP guidelines on managing drug product shortages in hospitals and health systems.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Am J Health-Syst Pharm. 66:1399-40.",
        "Grennan, Matthew. 2012. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Price Discrimination and Bargaining: Empirical Evidence from Medical Devices.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Forthcoming, The American Economic Review.",
        "Hobson, Katherine. 2010. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Drug Shortages Accompanied By Lack of Info, \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Near Misses,\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Deaths.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Wall Street Journal Health Blog. September 23, 2010.",
        "Medicare Payment Advisory Commission. 2003. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Report to Congress: Variation and Innovation in Medicare.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Chapter 9: Medicare Payments for Outpatient Drugs Under Part B. June 2003.",
        "Office of Inspector General. 2005. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Medicaid Drug Price Comparison: Average Sales Price to Average Wholesale Price.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d OEI-03-05-00200. June 2005.",
        "Rabin, Roni Caryn. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Drug Scarcity\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Dire Cost, And Some Ways to Cope.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New York Times. December 13, 2011.",
        "Scott Morton, Fiona M. 1999. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Entry Decisions in the Generic Pharmaceutical Industry.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d The RAND Journal of Economics, 30(3): pp. 421\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c440.",
        "U.S. Department of Health and Human Services. 2011. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Economic Analysis of the Causes of Drug Shortages.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Assistant Secretary for Planning and Evaluation. October 2011. Manufacturers Ben Venue/Bedford Labs, Daiichi Sankyo, Hospira, APP/Fresenius, Sandoz, Teva, West-Ward Wholesale Distributors Cardinal, McKesson, Amerisource, \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6 Group Purchasing Organizations (GPO\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s) Novation, MedAssets, Premier\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6 Physicians\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 Offices Hospitals Health Insurance Providers Medicare, Medicaid, Unitedhealth, Aetna, Blue Cross Blue Shield, \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6 Patients"
    ]
}